Europe and the US are almost certainly still a year ahead of licensing gene treatment, on the other hand, there are presently at least two experimental trials trying out gene treatment for mesothelioma. They are the University of Pennsylvania and the Louisiana State University. By bad luck, research about gene treatment took a big blow while young Jesse Gelsinger expired in 1999 for the period of a gene treatment experimental trial at the University of Pennsylvania.
Just the same, at the present China is the just country in the world that has given authoritative approval to gene treatment as early as now. On October 16, 2003, the medicine called Gendicine was given permission to use by the State Food and Drug Administration of China. Gendicine medicine had tried for more than 5 years of medical experimental trials earlier than it was judged to be right. They have at present used this treatment on over 4500 people and have kept up their patient's improvement for more than 6 years. At this time, tens of hundreds of cancer affected people from through out the world are going to Beijing to obtain this leading edge Gene therapy.
The medical experimental trials of Gendicine are use by 135 patients and effects revealed that 64% of patients indicated tumor regression later than 8 weekly doses in association with radiation treatment. In accordance with the medical experimental trial outcomes, with Gendicine and chemotherapy and radiation treatment can recover the efficiency by 3 times. The consequence of Gendicine is just a usual fever during the night.
In view of the fact that there are no further gene treatments established by authorities in the world, lots of hopeless cancer patients from though out the world are going to Beijing, China to entertain gene treatment with Gendicine.
One patient from Texas had cancer of tongue that reached to his lymph gland and has only two months of life as said by doctors. He got gene treatment with Gendicine and chemotherapy from Beijing for around 30,000 USD.
After two rounds of therapy, after two months, a presubscribed scan repot showed that the patient was cancer free. The debate about this story is that although he was cancer free there are a few uncertainties as whatever cured him the chemotherapy or Gendicine. A cancer professional doctor commented that "In accordance with my analysis, there's actually no way of showing whether one or another caused tumor to reduce".
In a sound healthy cell, it has a gene named as p53 gene, which can restore by replacing some part of DNA, hold cell growth, and starts a cellular self damage if the cell-break is too serious as for of cancer. On the other hand, in a research by the Chinese Academy of Preventive Medicine in Beijing, which revealed that there was a higher possibility of p53 gene-break in cancers involving asbestos for instance mesothelioma?
Gendicine works by activating the p53 gene that does something as tumor suppressant however is block off in a damaged cell since it may be inactivated by mutagens.
Add new comment